SGMT
Sagimet Biosciences Inc. Class A · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website agimet.com
- Employees(FY) 9
- ISIN US7867001049
Performance
+1.09%
1W
+10.53%
1M
-38.81%
3M
+98.28%
6M
-14.76%
YTD
-71.03%
1Y
Profile
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Technical Analysis of SGMT 2024-05-10
Overview:
In analyzing the technical indicators for SGMT over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the upcoming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been steadily increasing, i...
Recent News & Updates
- 2024-05-15 20:00
- 2024-05-15 00:53
- 2024-05-14 20:00
- 2024-05-06 20:00
- 2024-05-05 20:00
- 2024-04-21 20:00
- 2024-03-27 04:01
- 2024-03-24 19:00
- 2024-03-24 18:15
- 2024-02-28 19:00
- 2024-01-25 07:58
- 2024-01-23 04:45
- 2024-01-22 10:10
- 2024-01-21 18:00
- 2023-12-03 19:00
- 2023-11-27 19:00
- 2023-11-21 19:00
- 2023-11-12 19:00
- 2023-11-09 19:30
- 2023-10-23 23:00
- 2023-10-18 04:05
- 2023-09-27 04:05
- 2023-08-28 22:21
Load Up, Says Goldman Sachs About These 2 Strong Buy Stocks(Yahoo Finance)
- 2023-08-21 04:02
- 2023-08-15 04:04
- 2023-08-07 22:02
- 2023-07-20 04:05
Sagimet Biosciences Announces Leadership Changes(Yahoo Finance)
- 2023-07-13 09:10
Page 1 of 1
previousnext